Stewart Appelrouth

Insider Reports History

Location
Ocala, FL
Signature
/s/ Stewart Appelrouth
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Stewart Appelrouth:

Company Role Class Num Shares Value Price $ Report Date Ownership
AIM ImmunoTech Inc. Director Common Stock 388,729 $76,968 $0.1980 31 Dec 2024 Direct

Insider Reports Filed by Stewart Appelrouth

Symbol Company Period Transactions Value $ Form Type Role Filing Time
AIMI AIM ImmunoTech Inc. 31 Dec 2024 1 +$1,736 4 Director 03 Jan 2025, 16:35
AIMI AIM ImmunoTech Inc. 13 Dec 2024 1 +$5,208 4 Director 17 Dec 2024, 17:00
AIMI AIM ImmunoTech Inc. 02 Dec 2024 2 +$2,356 4 Director 04 Dec 2024, 16:05
AIMI AIM ImmunoTech Inc. 02 Dec 2024 1 +$5,208 4 Director 03 Dec 2024, 18:33
AIMI AIM ImmunoTech Inc. 20 Nov 2024 1 +$15,817 4 Director 21 Nov 2024, 12:02
AIMI AIM ImmunoTech Inc. 15 Mar 2024 1 +$30,000 4 Director 18 Mar 2024, 15:01
AIMI AIM ImmunoTech Inc. 08 Mar 2023 22 -$83,896 4 Director 10 Mar 2023, 15:05
AIMI AIM ImmunoTech Inc. 03 Jan 2023 1 +$25,000 4 Director 04 Jan 2023, 06:30
AIMI AIM ImmunoTech Inc. 30 Nov 2022 1 $0 4 Director 02 Dec 2022, 15:50
AIMI AIM ImmunoTech Inc. 25 Apr 2022 1 +$26,215 4 Director 27 Apr 2022, 15:46
AIMI AIM ImmunoTech Inc. 03 Mar 2022 1 $0 4 Director 04 Mar 2022, 08:59
AIMI AIM ImmunoTech Inc. 24 Nov 2021 1 +$24,999 4 Director 24 Nov 2021, 12:57
AIMI AIM ImmunoTech Inc. 11 Nov 2021 1 $0 4 Director 15 Nov 2021, 16:04
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .